Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.

Stella M, Giuliani M, Biolchi A, Tomei S, De Paola R, Bai X, Borrow R, Lucidarme J, La Gaetana R, Toneatto D, Pizza M, Serino L, Mori E, Giuliani MM.

Hum Vaccin Immunother. 2019 Dec 6:1-4. doi: 10.1080/21645515.2019.1688039. [Epub ahead of print]

PMID:
31770063
2.

Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.

Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, Ramsay ME, Borrow R, Ladhani SN.

J Infect. 2019 Nov 9. pii: S0163-4453(19)30339-1. doi: 10.1016/j.jinf.2019.11.001. [Epub ahead of print]

PMID:
31715210
3.

Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe.

Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erdősi T, Galajeva J, Křížová P, Lucidarme J, Mironov K, Nurmatov Z, Pana M, Rahimov E, Savrasova L, Skoczyńska A, Smith V, Taha MK, Titov L, Vázquez J, Yeraliyeva L.

J Infect. 2019 Dec;79(6):528-541. doi: 10.1016/j.jinf.2019.10.018. Epub 2019 Nov 1.

4.

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence.

Bratcher HB, Rodrigues CMC, Finn A, Wootton M, Cameron JC, Smith A, Heath P, Ladhani S, Snape MD, Pollard AJ, Cunningham R, Borrow R, Trotter C, Gray SJ, Maiden MCJ, MacLennan JM.

Version 2. Wellcome Open Res. 2019 Oct 28 [revised 2019 Jan 1];4:118. doi: 10.12688/wellcomeopenres.15362.2. eCollection 2019.

5.

13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment.

Bate J, Borrow R, Chisholm J, Clark S, Dixon E, Faust SN, Galanopoulou A, Goldblatt D, Heath PT, Maishman T, Mapstone S, Patel S, Williams AP, Gray JC.

Clin Infect Dis. 2019 Oct 5. pii: ciz965. doi: 10.1093/cid/ciz965. [Epub ahead of print]

PMID:
31586206
6.

Genomic characterization of novel Neisseria species.

Diallo K, MacLennan J, Harrison OB, Msefula C, Sow SO, Daugla DM, Johnson E, Trotter C, MacLennan CA, Parkhill J, Borrow R, Greenwood BM, Maiden MCJ.

Sci Rep. 2019 Sep 24;9(1):13742. doi: 10.1038/s41598-019-50203-2.

7.

Comparative genomic analyses of Chinese serogroup W ST-11 complex Neisseria meningitidis isolates.

Zhu B, Lucidarme J, Bai X, Guo P, Zhang A, Borrow R, Gao W, Xu L, Gao Y, Shao Z.

J Infect. 2019 Aug 29. pii: S0163-4453(19)30259-2. doi: 10.1016/j.jinf.2019.08.019. [Epub ahead of print]

PMID:
31473270
8.

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.

Oligbu G, Collins S, Djennad A, Sheppard CL, Fry NK, Andrews NJ, Borrow R, Ramsay ME, Ladhani SN.

Emerg Infect Dis. 2019 Sep;25(9):1708-1718. doi: 10.3201/eid2509.180747.

9.

Outbreak strain characterisation and pharyngeal carriage detection following a protracted group B meningococcal outbreak in adolescents in South-West England.

Clark SA, Lucidarme J, Angel G, Lekshmi A, Morales-Aza B, Willerton L, Campbell H, Gray SJ, Ladhani SN, Wade M, Ramsay M, Yates J, Finn A, Borrow R.

Sci Rep. 2019 Jul 10;9(1):9990. doi: 10.1038/s41598-019-46483-3.

10.

Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).

Ladhani SN, Campbell H, Lucidarme J, Gray S, Parikh S, Willerton L, Clark SA, Lekshmi A, Walker A, Patel S, Bai X, Ramsay M, Borrow R.

BMC Infect Dis. 2019 Jun 14;19(1):522. doi: 10.1186/s12879-019-4146-5.

11.

Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015.

Lawler J, Lucidarme J, Parikh S, Smith L, Campbell H, Borrow R, Gray S, Foster K, Ladhani S.

Euro Surveill. 2019 Jun;24(23). doi: 10.2807/1560-7917.ES.2019.24.23.1900070.

12.

Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial.

Tashani M, Badahdah AM, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Louth J, Rashid H, Borrow R, Booy R.

Vaccine. 2019 Jun 12;37(27):3562-3567. doi: 10.1016/j.vaccine.2019.05.025. Epub 2019 May 23.

PMID:
31128875
13.

Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 Lineage.

Green LR, Dave N, Adewoye AB, Lucidarme J, Clark SA, Oldfield NJ, Turner DPJ, Borrow R, Bayliss CD.

J Infect Dis. 2019 Aug 30;220(7):1109-1117. doi: 10.1093/infdis/jiz275.

14.

B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis.

Marshall HS, McMillan M, Koehler A, Lawrence A, MacLennan J, Maiden M, Ramsay M, Ladhani SN, Trotter C, Borrow R, Finn A, Sullivan T, Richmond P, Kahler C, Whelan J, Vadivelu K.

BMJ Open. 2019 May 6;9(5):e027233. doi: 10.1136/bmjopen-2018-027233.

15.

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, Emonet S, Caugant DA, Toropainen M, Vazquez J, Waśko I, Knol MJ, Jacobsson S, Rodrigues Bettencourt C, Musilek M, Born R, Vogel U, Borrow R.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800245.

16.

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Findlow H, Tapia MD, Sow SO, Haidara FC, Coulibaly F, Keita AM, Diallo F, Doumbia M, Traore A, Schluterman N, Clark DA, Borrow R, Levine MM.

Vaccine. 2019 Apr 24;37(18):2477-2481. doi: 10.1016/j.vaccine.2019.03.045. Epub 2019 Apr 2.

PMID:
30952500
17.

Lower risk of invasive meningococcal disease during pregnancy: national prospective surveillance in England, 2011-2014.

Parikh SR, Borrow R, Ramsay ME, Ladhani SN.

BJOG. 2019 Jul;126(8):1052-1057. doi: 10.1111/1471-0528.15701. Epub 2019 May 8.

PMID:
30932328
18.

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines.

Findlow J, Balmer P, Borrow R.

Hum Vaccin Immunother. 2019;15(10):2491-2500. doi: 10.1080/21645515.2019.1593082. Epub 2019 Apr 23.

19.

Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.

Lucidarme J, Louth J, Townsend-Payne K, Borrow R.

Methods Mol Biol. 2019;1969:169-179. doi: 10.1007/978-1-4939-9202-7_12.

PMID:
30877677
20.

Serological surveillance of influenza in an English sentinel network: pilot study protocol.

de Lusignan S, Borrow R, Tripathy M, Linley E, Zambon M, Hoschler K, Ferreira F, Andrews N, Yonova I, Hriskova M, Rafi I, Pebody R.

BMJ Open. 2019 Mar 8;9(3):e024285. doi: 10.1136/bmjopen-2018-024285.

21.

Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials.

White M, Idoko O, Sow S, Diallo A, Kampmann B, Borrow R, Trotter C.

Lancet Infect Dis. 2019 Mar;19(3):327-336. doi: 10.1016/S1473-3099(18)30674-1. Epub 2019 Feb 10.

PMID:
30745277
22.

Risk factors for acquisition of meningococcal carriage in the African meningitis belt.

Cooper LV, Robson A, Trotter CL, Aseffa A, Collard JM, Daugla DM, Diallo A, Hodgson A, Jusot JF, Omotara B, Sow S, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Chandramohan D, Borrow R, Maiden MCJ, Greenwood B, Stuart JM; MenAfriCar Consortium.

Trop Med Int Health. 2019 Apr;24(4):392-400. doi: 10.1111/tmi.13203. Epub 2019 Feb 6.

23.

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D.

Vaccine. 2019 Feb 8;37(7):991-1000. doi: 10.1016/j.vaccine.2018.12.061. Epub 2019 Jan 17.

24.

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.

Findlow H, Campbell H, Lucidarme J, Andrews N, Linley E, Ladhani S, Borrow R.

Euro Surveill. 2019 Jan;24(1). doi: 10.2807/1560-7917.ES.2019.24.1.1700818.

25.

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Linley E, Bell A, Gritzfeld JF, Borrow R.

Vaccines (Basel). 2019 Jan 3;7(1). pii: E4. doi: 10.3390/vaccines7010004.

26.

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.

Semchenko EA, Tan A, Borrow R, Seib KL.

Clin Infect Dis. 2019 Sep 13;69(7):1101-1111. doi: 10.1093/cid/ciy1061.

27.

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, Sáfadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, Vázquez JA, Zhu B.

Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27. Review.

PMID:
30526162
28.

Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt.

Diallo K, Coulibaly MD, Rebbetts LS, Harrison OB, Lucidarme J, Gamougam K, Tekletsion YK, Bugri A, Toure A, Issaka B, Dieng M, Trotter C, Collard JM, Sow SO, Wang X, Mayer LW, Borrow R, Greenwood BM, Maiden MCJ, Manigart O; MenAfriCar Consortium.

PLoS One. 2018 Dec 5;13(12):e0206453. doi: 10.1371/journal.pone.0206453. eCollection 2018.

29.

Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?

Yaro S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, Kpoda H, Findlow H, Tall H, Seanehia J, Martin C, Ouedraogo JB, Gessner B, Meda N, Borrow R, Trotter C, Mueller JE.

Clin Infect Dis. 2019 Jan 18;68(3):435-443. doi: 10.1093/cid/ciy488.

PMID:
30481265
30.

Invasive meningococcal disease as a cause of sudden and unexpected death in a teenager: The public health importance of confirming the diagnosis.

Campbell H, Borrow R, Arumugam C, Ramsay M, Ladhani SN.

J Infect. 2019 Apr;78(4):323-337. doi: 10.1016/j.jinf.2018.11.004. Epub 2018 Nov 23. No abstract available.

PMID:
30476492
31.

Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.

Vesikari T, Borrow R, Da Costa X, Thomas S, Eymin C, Boisnard F, Lockhart S.

Vaccine. 2018 Dec 18;36(52):8019-8027. doi: 10.1016/j.vaccine.2018.10.100. Epub 2018 Nov 22.

32.

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.

Biolchi A, Tomei S, Santini L, Welsch JA, Toneatto D, Gaitatzis N, Bai X, Borrow R, Giuliani MM, Mori E, Pizza M.

Hum Vaccin Immunother. 2019;15(3):725-731. doi: 10.1080/21645515.2018.1537756. Epub 2019 Jan 2.

33.

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland.

Mulhall RM, Bennett D, Cunney R, Borrow R, Lucidarme J, Findlow J, Jolley KA, Bray J, Maiden MCJ, Moschioni M, Serino L, Stella M, Medini D.

mSphere. 2018 Aug 22;3(4). pii: e00196-18. doi: 10.1128/mSphere.00196-18.

34.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS, Chaudhari A, Kulkarni PS, Borrow R, Findlow H, Brown V, McDonough ML, Dally L, Alderson MR.

Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14.

PMID:
30120069
35.

B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents.

Marshall HS, McMillan M, Koehler A, Lawrence A, MacLennan JM, Maiden MCJ, Ramsay M, Ladhani SN, Trotter C, Borrow R, Finn A, Sullivan T, Richmond P, Kahler CM, Whelan J, Vadivelu K.

BMJ Open. 2018 Jul 10;8(7):e020988. doi: 10.1136/bmjopen-2017-020988.

36.

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.

Green LR, Lucidarme J, Dave N, Chan H, Clark S, Borrow R, Bayliss CD.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00204-18. doi: 10.1128/JCM.00204-18. Print 2018 Sep.

37.

Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.

Makwana A, Sheppard C, Borrow R, Fry N, Andrews NJ, Ladhani SN.

Pediatr Infect Dis J. 2018 Jul;37(7):697-703. doi: 10.1097/INF.0000000000001845.

PMID:
29889811
38.

Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.

Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Findlow H, Borrow R, Booy R.

Vaccine. 2018 Jul 5;36(29):4375-4382. doi: 10.1016/j.vaccine.2018.04.033. Epub 2018 Jun 5.

PMID:
29880243
39.

Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.

Cayrou C, Akinduko AA, Mirkes EM, Lucidarme J, Clark SA, Green LR, Cooper HJ, Morrissey J, Borrow R, Bayliss CD.

PLoS One. 2018 May 30;13(5):e0197186. doi: 10.1371/journal.pone.0197186. eCollection 2018.

40.

Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015.

Parikh SR, Campbell H, Gray SJ, Beebeejaun K, Ribeiro S, Borrow R, Ramsay ME, Ladhani SN.

Vaccine. 2018 Jun 18;36(26):3876-3881. doi: 10.1016/j.vaccine.2018.02.038. Epub 2018 Apr 24.

PMID:
29699791
41.

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.

Rodrigues CMC, Lucidarme J, Borrow R, Smith A, Cameron JC, Moxon ER, Maiden MCJ.

Emerg Infect Dis. 2018 Apr;24(4):673-682. doi: 10.3201/eid2404.171480.

42.

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS.

MBio. 2018 Mar 13;9(2). pii: e00036-18. doi: 10.1128/mBio.00036-18.

43.

Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI).

Li J, Shao Z, Liu G, Bai X, Borrow R, Chen M, Guo Q, Han Y, Li Y, Taha MK, Xu X, Xu X, Zheng H.

J Infect. 2018 May;76(5):429-437. doi: 10.1016/j.jinf.2018.01.007. Epub 2018 Feb 12. Review.

44.

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.

Norheim G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, Findlow H, Borrow R, Xie O, Nagaputra J, Ramasamy R, Dold C, Tamekloe TA, Rollier CS, Watt H, Kere AB, Næss LM, Pollard AJ.

Vaccine. 2018 Feb 28;36(10):1297-1303. doi: 10.1016/j.vaccine.2018.01.031. Epub 2018 Feb 2.

45.

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.

Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, Andrews NJ, Miller E, Ramsay ME.

Lancet Infect Dis. 2018 Apr;18(4):441-451. doi: 10.1016/S1473-3099(18)30052-5. Epub 2018 Jan 26. Erratum in: Lancet Infect Dis. 2018 Feb 6;:.

PMID:
29395999
46.

Growing evidence supports 4CMenB effectiveness.

Ladhani SN, Borrow R, Andrews NJ.

Lancet Infect Dis. 2018 Apr;18(4):370-371. doi: 10.1016/S1473-3099(18)30051-3. Epub 2018 Jan 19. No abstract available.

PMID:
29371069
47.

Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.

Oligbu G, Collins S, Andrews N, Sheppard CL, Fry NK, Slack MPE, Borrow R, Ladhani SN.

Clin Infect Dis. 2017 Oct 1;65(7):1191-1198. doi: 10.1093/cid/cix418.

PMID:
29309553
48.

Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.

Collins S, Litt D, Almond R, Findlow J, Linley E, Ramsay M, Borrow R, Ladhani S.

J Infect. 2018 Apr;76(4):335-341. doi: 10.1016/j.jinf.2017.12.010. Epub 2017 Dec 28.

PMID:
29289561
49.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.

Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A.

Lancet Public Health. 2017 Oct;2(10):e473-e482. doi: 10.1016/S2468-2667(17)30157-3. Epub 2017 Aug 24.

50.

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.

Basta NE, Berthe A, Keita M, Onwuchekwa U, Tamboura B, Traore A, Hassan-King M, Manigart O, Nascimento M, Stuart JM, Trotter C, Blake J, Carr AD, Gray SJ, Newbold LS, Deng Y, Wolfson J, Halloran ME, Greenwood B, Borrow R, Sow SO.

J Infect. 2018 Feb;76(2):140-148. doi: 10.1016/j.jinf.2017.11.006. Epub 2017 Nov 29.

Supplemental Content

Loading ...
Support Center